FDA Drug recall D-1218-2020
Bi-Est (8:2)/Progesterone/Testosterone 0.5/75 mg per 0.2 mL Cream 6 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL
- FDA Drug
- Class II
- terminated
- Published 2020-04-22
On 2020-04-22 the FDA classified a Class II recall of Bi-Est (8:2)/Progesterone/Testosterone 0.5/75 mg per 0.2 mL Cream 6 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL by The Medicine Shoppe Pharmacy, citing lack of Processing Control.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1218-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-04-06 |
| Published | 2020-04-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | The Medicine Shoppe Pharmacy |
| Distribution | FL |
Product
Bi-Est (8:2)/Progesterone/Testosterone 0.5/75 mg per 0.2 mL Cream 6 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL
Reason
Lack of Processing Control
Identifiers
| code_info | Lot: 44518 Discard by: 3/15/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1218-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.